Open AccessA Leydig Cell Tumor of the Ovary Resulting in Extreme Hyperandrogenism, Erythrocytosis, and Recurrent Pulmonary Embolism
Author(s) -
Pinar Kozan,
Santhi Chalasani,
David J. Handelsman,
Anne H. Pike,
Bronwyn A. Crawford
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-3108
Subject(s) - medicine , endocrinology , virilization , hyperandrogenism , context (archaeology) , androgen , polycystic ovary , hormone , biology , obesity , insulin resistance , paleontology
Secondary erythrocytosis due to androgens is most commonly seen in the context of T replacement therapy in men. Leydig cell ovarian tumors are a rare cause of virilization, erythrocytosis, and thromboembolism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom